Bayban’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-25
Closed -$8.98K – 614
2026
Q2
$8.98K Hold
25
– – 0.01% 414
2026
Q1
$6.27K Sell
25
-74
-75% -$18.4K 0.01% 451
2025
Q4
$27.2K Buy
+99
New +$27.1K 0.02% 290

Other funds holding WST

Bayban's WST Position: Q3 2026 in Review

Bayban sold out of West Pharmaceutical (WST) in Q3 2026, closing a stake of 25 shares — an estimated $8.98K sold.

Bayban first reported a position in WST in Q4 2025 and held it in 3 quarters. The position peaked at $27.2K in Q4 2025. 878 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Bayban reported no remaining West Pharmaceutical position as of Q3 2026 after selling out during the quarter.
  • Bayban sold 25 West Pharmaceutical shares in Q3 2026, an estimated $8.98K.
  • Bayban first reported a position in West Pharmaceutical in Q4 2025 and held it in 3 quarters.
  • Bayban's West Pharmaceutical position peaked at $27.2K in Q4 2025.
  • 878 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Bayban's 13F filing for Q3 2026, filed 5 Nov 2026.